Dose Escalation Cohort to be Initiated in Adaptimmune's MAGE-A4 SPEAR T-Cell Basket Study

Dose Escalation Cohort to be Initiated in Adaptimmune's MAGE-A4 SPEAR T-Cell Basket Study

Submitted by admin on August 15, 2018 - 9:52am
Source: 
CP Wire
News Tags: 
Adaptimmune
MAGE-A4
solid tumors
Headline: 
Dose Escalation Cohort to be Initiated in Adaptimmune's MAGE-A4 SPEAR T-Cell Basket Study
snippet: 

Adaptimmune Therapeutics plc (Nasdaq:ADAP) announced on 8/14/18 a favorable review of safety data from the second dose cohort of patients who received one billion transduced SPEAR T‑cells targeting MAGE-A4 in the ongoing basket study in nine solid tumor indications.

Do Not Allow Advertisers to Use My Personal information